FR2983077B1 - Seringue - Google Patents

Seringue Download PDF

Info

Publication number
FR2983077B1
FR2983077B1 FR1350671A FR1350671A FR2983077B1 FR 2983077 B1 FR2983077 B1 FR 2983077B1 FR 1350671 A FR1350671 A FR 1350671A FR 1350671 A FR1350671 A FR 1350671A FR 2983077 B1 FR2983077 B1 FR 2983077B1
Authority
FR
France
Prior art keywords
syringe
relates
present
small volume
ophthalmic injections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1350671A
Other languages
English (en)
Other versions
FR2983077A1 (fr
Inventor
Juergen Sigg
Christophe Royer
Andrew Mark Bryant
Heinrich Martin Buettgen
Marie Picci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48051683&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2983077(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2012101678A external-priority patent/AU2012101678B4/en
Priority claimed from AU2013100070A external-priority patent/AU2013100070B4/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of FR2983077A1 publication Critical patent/FR2983077A1/fr
Application granted granted Critical
Publication of FR2983077B1 publication Critical patent/FR2983077B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104—Caps for syringes without needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
    • A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0612—Eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513—Piston constructions to improve sealing or sliding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une seringue, en particulier une seringue de petit volume telle qu'une seringue appropriée pour les injections ophtalmiques.
FR1350671A 2012-07-03 2013-01-25 Seringue Active FR2983077B1 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
EP12174860 2012-07-03
EP12174860.2 2012-07-03
EP12189649 2012-10-23
EP12189649.2 2012-10-23
AU2012101678A AU2012101678B4 (en) 2012-07-03 2012-11-16 Use of device
DE202012011016U DE202012011016U1 (de) 2012-07-03 2012-11-16 Aflibercept-Spritze
AU2012101677A AU2012101677B4 (en) 2012-07-03 2012-11-16 Device
DE202012011260U DE202012011260U1 (de) 2012-07-03 2012-11-23 Ranibizumab-Spritze
DE202012011259U DE202012011259U1 (de) 2012-07-03 2012-11-23 Bevacizumab-Spritze
EP12195360 2012-12-03
EP12195360.8 2012-12-03
DE201320000688 DE202013000688U1 (de) 2012-07-03 2013-01-23 Glas-Spritze
AU2013100070A AU2013100070B4 (en) 2012-07-03 2013-01-23 Use of device
AU2013100071A AU2013100071C4 (en) 2012-07-03 2013-01-23 Device

Publications (2)

Publication Number Publication Date
FR2983077A1 FR2983077A1 (fr) 2013-05-31
FR2983077B1 true FR2983077B1 (fr) 2018-09-14

Family

ID=48051683

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1350671A Active FR2983077B1 (fr) 2012-07-03 2013-01-25 Seringue

Country Status (40)

Country Link
US (1) US9220631B2 (fr)
EP (5) EP2869813B1 (fr)
JP (2) JP5744927B2 (fr)
KR (7) KR102395557B1 (fr)
CN (4) CN111249062A (fr)
AR (1) AR090059A1 (fr)
AU (1) AU2013201624A1 (fr)
BR (2) BR122020020290B1 (fr)
CA (1) CA2803566A1 (fr)
CH (1) CH706741B1 (fr)
CL (1) CL2014003619A1 (fr)
CO (1) CO7151483A2 (fr)
CY (2) CY1121497T1 (fr)
DE (1) DE202013000688U1 (fr)
DK (4) DK3685826T3 (fr)
EA (1) EA031583B1 (fr)
EC (1) ECSP15004005A (fr)
ES (4) ES2882254T3 (fr)
FR (1) FR2983077B1 (fr)
GT (1) GT201400300A (fr)
HK (1) HK1188404A1 (fr)
HR (4) HRP20220535T1 (fr)
HU (3) HUE057746T2 (fr)
IL (2) IL236296B (fr)
JO (2) JOP20200175A1 (fr)
LT (4) LT3381444T (fr)
MA (1) MA37740B2 (fr)
MX (1) MX358323B (fr)
MY (1) MY164536A (fr)
NZ (1) NZ702980A (fr)
PE (1) PE20150196A1 (fr)
PH (1) PH12014502785A1 (fr)
PL (4) PL3656373T3 (fr)
PT (1) PT2869813T (fr)
SG (1) SG11201408261UA (fr)
SI (4) SI3381444T1 (fr)
TN (1) TN2014000517A1 (fr)
TW (1) TWI632920B (fr)
WO (1) WO2014005728A1 (fr)
ZA (1) ZA201409411B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060217311A1 (en) 2005-03-25 2006-09-28 Daniel Dix VEGF antagonist formulations
SI2364691T1 (sl) 2006-06-16 2013-08-30 Regeneron Pharmaceuticals, Inc. Formulacije antagonista VEGF, primerne za intravitrealno dajanje
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
EP2776603B1 (fr) 2011-11-11 2019-03-06 SiO2 Medical Products, Inc. Revêtement de passivation, de protection de ph ou à pouvoir lubrifiant pour conditionnement pharmaceutique, processus et appareil de revêtement
PL3679922T3 (pl) 2012-06-01 2022-01-03 Novartis Ag Strzykawka
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
KR102336796B1 (ko) 2013-03-11 2021-12-10 에스아이오2 메디컬 프로덕츠, 인크. 코팅된 패키징
US10251815B2 (en) * 2013-03-13 2019-04-09 Rush University Medical Center Delivery device and storage system for oropharyngeal administration of mother's colostrum and milk
US20140350518A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
EP3122917B1 (fr) 2014-03-28 2020-05-06 SiO2 Medical Products, Inc. Revêtements antistatiques pour des récipients en plastique
EP3828202A1 (fr) * 2014-05-12 2021-06-02 Formycon AG Seringue en plastique préremplie contenant un antagoniste de vegf
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
EP3058974A1 (fr) 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Dispositif d'injection avec dispositif supplémentaire
EP3274026A2 (fr) 2015-03-23 2018-01-31 Sanofi-Aventis Deutschland GmbH Dispositif d'injection
MA41906A (fr) 2015-04-10 2018-02-13 Dompe Farm Spa Dispositif de distribution de gouttes oculaires
WO2018218013A2 (fr) 2017-05-24 2018-11-29 Sio2 Medical Products, Inc. Conditionnement pharmaceutique stérilisable pour formulations ophtalmiques
MX2018006092A (es) 2015-11-18 2019-01-31 Formycon Ag Envase farmacéutico precargado que comprende una formulación líquida de un antagonista del vegf.
JP7430485B2 (ja) 2015-11-18 2024-02-13 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド 眼科用製剤のための薬剤パッケージ
WO2017085253A1 (fr) * 2015-11-18 2017-05-26 Formycon Ag Seringue en plastique préremplie contenant un antagoniste du facteur de croissance de l'endothélium vasculaire (vegf)
KR102183910B1 (ko) 2015-12-03 2020-11-27 리제너론 파마슈티칼스 인코포레이티드 항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법
SG11201805420SA (en) 2015-12-30 2018-07-30 Kodiak Sciences Inc Antibodies and conjugates thereof
KR102385255B1 (ko) * 2016-04-15 2022-04-08 산텐 세이야꾸 가부시키가이샤 정확하고 정밀한 마이크로리터 투여 시린지
US20170349313A1 (en) * 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
CN109312182B (zh) 2016-06-17 2021-12-24 花王株式会社 水性油墨
TWI737742B (zh) * 2016-06-22 2021-09-01 德商梅茲製藥有限兩合公司 肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用
ITUA20162072A1 (it) * 2016-06-30 2017-12-30 Platinum Corp Srl Dropper a volume controllato
WO2018037467A1 (fr) 2016-08-22 2018-03-01 富士機械製造株式会社 Procédé de production de peroxyde d'hydrogène aqueux et procédé de stérilisation d'un objet à stériliser
US10537683B2 (en) 2016-11-03 2020-01-21 Johnson & Johnson Surgical Vision, Inc. Syringe finger grip
KR102535910B1 (ko) 2017-03-27 2023-05-25 리제너론 파아마슈티컬스, 인크. 살균 방법
CN111787915A (zh) 2017-04-12 2020-10-16 尤里根制药股份有限公司 注射器中包含局部麻醉剂、缓冲剂和糖胺聚糖的稳定性提高的制品
US10898649B2 (en) 2017-05-05 2021-01-26 Alcon Inc. Syringe
EP3630043A1 (fr) 2017-05-24 2020-04-08 Formycon AG Conditionnements pharmaceutiques pré-remplis stérilisables comprenant une formulation liquide d'un antagoniste du vegf
US11090445B2 (en) 2017-06-16 2021-08-17 Credence Medsystems, Inc. System and method for safety syringe
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
FR3072297B1 (fr) * 2017-10-17 2023-05-12 Edix Sa Dispositif d'injection manuelle
EP3723828B1 (fr) 2017-12-13 2023-09-13 Regeneron Pharmaceuticals, Inc. Dispositifs et procédés d'administration de doses de précision
JP2021511906A (ja) 2018-02-02 2021-05-13 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト プレフィルドシリンジおよびプレフィルドシリンジを滅菌する方法
CA3096847A1 (fr) * 2018-04-09 2019-10-17 Sio2 Medical Products, Inc. Ensembles pistons etirables
US20210146054A1 (en) * 2018-04-24 2021-05-20 W. L. Gore & Associates, Inc. Medical Delivery Devices With Inhibited Oxygen Permeation
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
US20210260300A1 (en) * 2018-06-01 2021-08-26 Sun Pharma Advanced Research Company Limited An injection device
EP3870119A4 (fr) * 2018-10-26 2022-07-20 Singapore Health Services Pte. Ltd. Dispositif et procédé d'extraction et d'injection ophtalmiques
US11419991B2 (en) 2018-11-13 2022-08-23 Credence Medsystems, Inc. System and method for microdose injection
WO2020109344A1 (fr) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Dispositif d'administration oculaire pour oligonucléotides antisens
WO2020109343A1 (fr) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Polythérapie pour le traitement de la dégénérescence maculaire
CN113194993A (zh) 2018-12-18 2021-07-30 诺华股份有限公司 含高浓度抗vegf抗体的蛋白质溶液配制品
CN110721026A (zh) * 2018-12-21 2020-01-24 南通市第一人民医院 一种眼科手术用取硅油装置防滑层的制备方法
EP3689397A1 (fr) * 2019-01-31 2020-08-05 SCHOTT Schweiz AG Corps de seringue, seringue et dispositif d'injection permettant d'injecter un milieu à haute viscosité
FR3093004B1 (fr) * 2019-02-21 2023-04-07 Dev Techniques Plastiques Procede de preparation d’une seringue
SG11202110788RA (en) * 2019-03-29 2021-10-28 Kortuc Inc Hydrogen peroxide solution-prefilled syringe having excellent hydrogen peroxide preservability by virtue of silicone oil (oil composition containing said silicone oil)
JP2022528596A (ja) 2019-04-18 2022-06-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 液体を投与するための投与装置
MA54325A (fr) 2019-06-05 2022-05-11 Regeneron Pharma Dispositifs et procédés pour l'administration précise de doses
US11912784B2 (en) 2019-10-10 2024-02-27 Kodiak Sciences Inc. Methods of treating an eye disorder
WO2021097353A2 (fr) 2019-11-14 2021-05-20 Congruence Medical Solutions, Llc Seringue de dosage variable
WO2021110910A2 (fr) 2019-12-05 2021-06-10 F. Hoffmann-La Roche Ag Seringue et procédé de test d'étanchéité
WO2021119544A1 (fr) * 2019-12-12 2021-06-17 Novartis Ag Dispositif d'injection et système de transfert de solution d'injection
EP4098298A4 (fr) * 2020-03-24 2023-07-19 TERUMO Kabushiki Kaisha Poignée de cylindre de seringue, ensemble cylindre et seringue
WO2021257911A1 (fr) 2020-06-17 2021-12-23 Credence Medsystems, Inc. Système et procédé pour l'injection de microdoses
JP2023550281A (ja) 2020-10-30 2023-12-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 流体の特に硝子体内投与のための投与デバイス
CA3201808A1 (fr) 2020-12-01 2022-06-09 Boehringer Ingelheim International Gmbh Dispositif d'administration destine, en particulier, a l'administration intravitreenne d'un fluide
US20240189517A1 (en) * 2020-12-29 2024-06-13 W.L. Gore & Associates, Inc. Drug injection stopper with thin film lubricant
EP4324501A1 (fr) * 2021-04-15 2024-02-21 Alteogen, Inc Seringue pré-remplie remplie d'un médicament liquide à faible dose, et son procédé de préparation
EP4389176A1 (fr) 2022-12-20 2024-06-26 W. L. Gore & Associates, Inc. Bouchons de seringue à faible force d'insertion, ensembles et procédés associés
CN117942456A (zh) * 2024-03-27 2024-04-30 山东永聚医药科技股份有限公司 缓释型非牛顿流体制剂用预灌封注射器及其制备工艺

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31789A (en) 1861-03-26 Bread-slicebi
DE2629557B2 (de) 1976-07-01 1980-05-14 Paul E. Dr.Med. 8000 Muenchen Doerr Einmai-Injektionsspritze
JPH0747045B2 (ja) * 1986-10-15 1995-05-24 株式会社大協精工 積層した注射器用滑栓
US4946441A (en) 1988-07-21 1990-08-07 Maurice Laderoute Limited use hypodermic syringe
JPH0725963Y2 (ja) 1989-11-06 1995-06-14 清坤 曽 緊急避難装置
WO1992008504A1 (fr) * 1990-11-17 1992-05-29 Santen Seiyaku Kabushiki Kaisha Cylindre de seringue a deux chambres
US5236604A (en) * 1991-05-29 1993-08-17 Sherwood Medical Company Serum separation blood collection tube and the method of using thereof
JP3186422B2 (ja) 1993-05-14 2001-07-11 武田薬品工業株式会社 プラスチゾル
US5405326A (en) 1993-08-26 1995-04-11 Habley Medical Technology Corporation Disposable safety syringe with retractable shuttle for luer lock needle
US5795337A (en) 1994-02-14 1998-08-18 Becton Dickinson And Company Syringe assembly and syringe stopper
US5688252A (en) 1994-09-30 1997-11-18 Takeda Chemical Industries, Ltd. Syringe
US5667495A (en) 1995-04-21 1997-09-16 Becton Dickinson France S.A. Backstop device for a syringe
US5607400A (en) * 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
DE19622283A1 (de) 1996-05-23 1997-11-27 Schering Ag Verfahren zur terminalen Sterilisierung von befüllten Spritzen
JP4078406B2 (ja) * 1997-01-22 2008-04-23 有限会社コーキ・エンジニアリング 注射器のシリンダの製造方法
AU743758B2 (en) 1997-04-07 2002-02-07 Genentech Inc. Anti-VEGF antibodies
JP3387775B2 (ja) 1997-05-22 2003-03-17 株式会社大協精工 注射器用密封栓及びプレフィルド注射器
US6200627B1 (en) * 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
EP1075293A1 (fr) * 1998-04-30 2001-02-14 Abbott Laboratories Ensemble seringue
USD430015S (en) 1998-06-11 2000-08-29 Pharmacia & Upjohn Ab Blister pack for a syringe
JP2001104480A (ja) * 1999-10-05 2001-04-17 Daikyo Seiko Ltd プラスチック製プレフィルド注射器の密封に使用するゴム製ピストン
JP2001340455A (ja) 2000-05-31 2001-12-11 Yoshino Kogyosho Co Ltd シリンジ容器
JP2002177388A (ja) 2000-12-15 2002-06-25 Daikyo Seiko Ltd 医薬・医療用既充填注射器
JP2002241264A (ja) * 2001-02-19 2002-08-28 Asahi Kasei Corp エルカトニンのプレフィルドシリンジ製剤
US20050154354A1 (en) * 2001-12-27 2005-07-14 Yoshihiko Kawasaki Cartridge syringe, cartridge and ophthalmologic syringe set having such syringe
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
US6688252B1 (en) 2002-12-11 2004-02-10 Gary Caravella Boat cover
EP1596909A2 (fr) 2003-02-27 2005-11-23 Baxter International Inc. Ensemble piston pour seringue
JP2004313369A (ja) 2003-04-15 2004-11-11 Menicon Co Ltd カートリッジ注入器、カートリッジ及び該注入器を備えた眼科用注入器セット
FR2855413B1 (fr) 2003-05-26 2005-12-30 Becton Dickinson France Seringue pre-remplie avec coiffe anti effraction
JP2007520276A (ja) * 2004-01-12 2007-07-26 アイサイエンス・インターベンショナル・コーポレーション 粘性材料のための注入器
US8124207B2 (en) 2004-03-02 2012-02-28 Sakhrani Vinay G Article with lubricated surface and method
US7750138B2 (en) 2004-06-08 2010-07-06 Chengdu Kanghong Biotechnologies Co. Ltd. Angiogenesis-inhibiting chimeric protein and the use
DK1802334T3 (da) * 2004-10-21 2012-10-15 Genentech Inc Fremgangsmåde til behandling af intraokulære, neovaskulære sygdomme
WO2006088650A2 (fr) * 2005-02-02 2006-08-24 Regeneron Pharmaceuticals, Inc. Methode de traitement de lesion oculaire par l'administration locale d'un inhibiteur de vegf
EP1888150A1 (fr) 2005-05-31 2008-02-20 Baxter International Inc. Cylindre creux en polypropylene pourvu d'un piston en caoutchouc coulissant
US20060293270A1 (en) * 2005-06-22 2006-12-28 Adamis Anthony P Methods and compositions for treating ocular disorders
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
FR2890316B1 (fr) * 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur.
WO2007035621A1 (fr) 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Seringue oculaire
WO2007035623A1 (fr) 2005-09-17 2007-03-29 Technology Group Northwest Inc. Systeme et methode pour une protection dirigee contre des attaques d'injection de code dans un dispositif informatique
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
ZA200803814B (en) * 2005-10-14 2010-02-24 Alcon Inc Method for treating primary and secondary forms of glaucoma
AT502791B1 (de) * 2006-04-06 2007-05-15 Pharma Consult Ges M B H & Co Injektionsspritze
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
CN101437543A (zh) * 2006-05-04 2009-05-20 佛维雅制药股份有限公司 用于治疗新生血管病的包含vegf抑制剂和丝氨酸蛋白酶的组合
SI2364691T1 (sl) 2006-06-16 2013-08-30 Regeneron Pharmaceuticals, Inc. Formulacije antagonista VEGF, primerne za intravitrealno dajanje
JP4131001B2 (ja) 2006-07-28 2008-08-13 大成化工株式会社 定量吐出装置
CN200973886Y (zh) * 2006-11-20 2007-11-14 骆忠林 一种注射器
WO2008077155A1 (fr) 2006-12-21 2008-06-26 Genentech, Inc. Stérilisation d'objets contenant des molécules biologiques
US8529521B2 (en) 2007-04-23 2013-09-10 Ultimed Inc. Low-dosage syringe
CN100563736C (zh) * 2007-06-02 2009-12-02 丁锐 一次性防刺伤注射器
CN101808686B (zh) 2007-06-12 2012-11-28 贝克顿·迪金森公司 具有失效机构的注射器
ATE535261T1 (de) * 2007-07-31 2011-12-15 Al Chi Mi A S R L Methode zum herstellen einer vorrichtung für ophthalmische behandlungen
WO2009030975A1 (fr) 2007-09-03 2009-03-12 Becton Dickinson France Dispositif médical comprenant une chambre siliconée et un moyen de fermeture pourvu d'un revêtement
WO2009030976A1 (fr) 2007-09-03 2009-03-12 Becton Dickinson France Dispositif médical et revêtement lisse pour ce dispositif
EP2235395B1 (fr) 2008-01-24 2011-11-16 Meflex Telecontrol Gmbh & Co. Kg Capuchon de recouvrement pour cable de commande, cable de commande, procede de fabrication d'un capuchon de recouvrement et procede de fabrication d'un cable de commande
DE102008005938A1 (de) * 2008-01-24 2009-07-30 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze und Verfahren zum Verpacken einer Spritze
CN103720587A (zh) 2008-02-07 2014-04-16 安姆根有限公司 稳定化的蛋白组合物
EP2298392A4 (fr) 2008-06-17 2015-01-28 Taisei Kako Co Injecteur
WO2009158613A1 (fr) 2008-06-26 2009-12-30 West Pharmaceutical Services, Inc. Procédé de revêtement de polyxylylène sur des surfaces fluoropolymères et dispositifs ainsi enduits
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
DK2358746T3 (da) 2008-11-03 2020-12-21 Molecular Partners Ag Bindingsproteiner til inhibering af vegf-a-receptorinteraktionen
WO2010064667A1 (fr) * 2008-12-03 2010-06-10 電気化学工業株式会社 Seringue
EP2432476A4 (fr) * 2009-05-01 2013-03-20 Ophthotech Corp Procédés de traitement ou de prévention de maladies ophtalmologiques
EA201190273A1 (ru) 2009-05-28 2012-12-28 Глаксо Груп Лимитед Комбинация антагониста tnf-альфа и антагониста vegf для применения в лечении или предупреждении заболеваний глаз
EP2266647A1 (fr) * 2009-06-25 2010-12-29 Sanofi-Aventis Deutschland GmbH Mécanisme d'entraînement pour dispositif d'administration de médicament
AR078060A1 (es) 2009-07-14 2011-10-12 Novartis Ag Descontaminacion de superficie de contenedores previamente llenados en empaque secundario
EP3202444B1 (fr) 2009-10-29 2021-05-19 W.L. Gore & Associates, Inc. Piston de seringue revêtu de eptfe
CN201578690U (zh) 2010-01-21 2010-09-15 王建友 一种注射器
US9408746B2 (en) 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
CA2795096C (fr) 2010-03-31 2021-10-26 Ocuject, Llc Dispositif et procede pour administrer un medicament par voie intra-oculaire
AR081361A1 (es) 2010-04-30 2012-08-29 Molecular Partners Ag Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
JP2012045046A (ja) 2010-08-24 2012-03-08 Gc Corp 歯科用シリンジ
FR2966044B1 (fr) 2010-10-18 2012-11-02 Sanofi Pasteur Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
WO2012117837A1 (fr) 2011-03-01 2012-09-07 テルモ株式会社 Seringue et ensemble seringue
SI2701773T1 (sl) 2011-04-25 2019-07-31 Icon Bioscience, Inc. Vodila odmerkov za injekcijsko brizgo
US20130012918A1 (en) 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method
US20140221934A1 (en) 2011-09-27 2014-08-07 Becton Dickinson France Use of plasma treated silicone oil as a coating in a medical injection device
US9421129B2 (en) 2012-04-02 2016-08-23 Ocuject, Llc Intraocular delivery devices and methods therefor
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
PL3679922T3 (pl) 2012-06-01 2022-01-03 Novartis Ag Strzykawka
AU2013100071C4 (en) 2012-07-03 2013-05-02 Novartis Ag Device
AU2012101678B4 (en) 2012-07-03 2013-01-24 Novartis Ag Use of device
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
WO2014134577A1 (fr) * 2013-03-01 2014-09-04 Sio2 Medical Products, Inc. Prétraitement par plasma ou par dépôt chimique en phase vapeur pour kit pharmaceutique lubrifié, procédé de revêtement et appareil

Also Published As

Publication number Publication date
HRP20220083T1 (hr) 2022-04-15
DK3381444T3 (da) 2021-08-09
ES2712152T3 (es) 2019-05-09
ES2906812T3 (es) 2022-04-20
KR102092427B1 (ko) 2020-04-17
PH12014502785B1 (en) 2015-02-02
KR102443606B1 (ko) 2022-09-14
BR122020020290B1 (pt) 2022-04-05
HK1188404A1 (en) 2014-05-02
AR090059A1 (es) 2014-10-15
EA201590139A1 (ru) 2015-07-30
ES2912848T3 (es) 2022-05-30
KR102395557B1 (ko) 2022-05-09
SI2869813T1 (sl) 2019-04-30
CN110115657A (zh) 2019-08-13
ZA201409411B (en) 2015-11-25
KR102487296B1 (ko) 2023-01-13
MY164536A (en) 2017-12-29
EP3656373A1 (fr) 2020-05-27
EP3656373B1 (fr) 2022-02-16
LT2869813T (lt) 2019-03-12
CL2014003619A1 (es) 2015-10-02
DK2869813T3 (en) 2019-03-18
FR2983077A1 (fr) 2013-05-31
EP3381444B1 (fr) 2021-05-19
CO7151483A2 (es) 2014-12-29
MA37740A1 (fr) 2016-11-30
KR20200029611A (ko) 2020-03-18
CA2803566A1 (fr) 2014-01-03
DK3656373T3 (da) 2022-05-16
KR20220130821A (ko) 2022-09-27
TW201402152A (zh) 2014-01-16
BR112014032990B1 (pt) 2022-01-04
KR20210156865A (ko) 2021-12-27
HUE055227T2 (hu) 2021-11-29
EP3685826B1 (fr) 2021-11-03
CY1124431T1 (el) 2022-07-22
LT3381444T (lt) 2021-08-25
NZ702980A (en) 2017-06-30
PT2869813T (pt) 2019-02-27
EP2869813B1 (fr) 2018-11-21
SI3381444T1 (sl) 2021-09-30
EA031583B1 (ru) 2019-01-31
ES2882254T3 (es) 2021-12-01
IL236296A0 (en) 2015-02-26
HRP20190300T1 (hr) 2019-04-05
SI3656373T1 (sl) 2022-06-30
LT3656373T (lt) 2022-05-10
KR20230013282A (ko) 2023-01-26
CN104427972A (zh) 2015-03-18
HUE042652T2 (hu) 2019-07-29
CH706741A2 (de) 2014-01-15
JP2014087678A (ja) 2014-05-15
EP3685826A1 (fr) 2020-07-29
HRP20211216T1 (hr) 2021-10-29
BR112014032990A2 (pt) 2018-03-06
KR20150030216A (ko) 2015-03-19
HUE057746T2 (hu) 2022-06-28
MA37740B2 (fr) 2020-10-28
PL3381444T3 (pl) 2021-11-22
ECSP15004005A (es) 2018-10-31
PL3656373T3 (pl) 2022-06-20
IL272915B (en) 2021-02-28
AU2013201624A1 (en) 2014-01-23
JP2014028114A (ja) 2014-02-13
MX2014015743A (es) 2015-07-23
KR20210113413A (ko) 2021-09-15
HRP20220535T1 (hr) 2022-07-08
TWI632920B (zh) 2018-08-21
JOP20200175A1 (ar) 2017-06-16
KR102299177B1 (ko) 2021-09-08
JO3655B1 (ar) 2020-08-27
PL2869813T3 (pl) 2019-05-31
JP6313038B2 (ja) 2018-04-18
CN111249062A (zh) 2020-06-09
WO2014005728A1 (fr) 2014-01-09
SI3685826T1 (sl) 2022-02-28
KR20220062681A (ko) 2022-05-17
IL236296B (en) 2020-04-30
EP3470058A1 (fr) 2019-04-17
PE20150196A1 (es) 2015-03-02
US9220631B2 (en) 2015-12-29
PH12014502785A1 (en) 2015-02-02
EP2869813A1 (fr) 2015-05-13
CH706741B1 (de) 2014-02-14
JP5744927B2 (ja) 2015-07-08
SG11201408261UA (en) 2015-01-29
US20140012227A1 (en) 2014-01-09
KR102341670B1 (ko) 2021-12-22
LT3685826T (lt) 2022-02-10
IL272915A (en) 2020-04-30
GT201400300A (es) 2015-10-15
MX358323B (es) 2018-08-14
DE202013000688U1 (de) 2013-03-05
CN112972828A (zh) 2021-06-18
DK3685826T3 (da) 2022-02-14
TN2014000517A1 (en) 2016-03-30
PL3685826T3 (pl) 2022-03-21
CY1121497T1 (el) 2020-05-29
EP3381444A1 (fr) 2018-10-03

Similar Documents

Publication Publication Date Title
FR2983077B1 (fr) Seringue
EA201590173A1 (ru) Иммуноконъюгаты, содержащие антитела к cd22
GT201400279A (es) Jeringa
MA33936B1 (fr) Antidotes pour anticoagulants
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
PH12014502406A1 (en) Anti-il-23p19 antibodies
IN2015DN03029A (fr)
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
FR2975600B1 (fr) Agents pour le traitement de tumeurs
FR2995713B1 (fr) Ecran d'affichage, en particulier pour autostereoscopie.
TR201821285T4 (tr) CCR3 antagonisti içeren farmasötik formülasyonlar.
MA42166B1 (fr) Seringue
CL2013000069A1 (es) Compuestos derivados de heterociclos fusionados, moduladores s1p; composicion farmaceutica; y uso en enfermedades neurodegenerativas.
MA34978B1 (fr) Antidotes pour anticoagulants
EA201590651A1 (ru) Фармацевтическая композиция, содержащая ребамипид
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
WO2014044793A3 (fr) Peptides de liaison à cd22
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
EA201301355A1 (ru) Композиция и таблетка, содержащая ралтегравир
CY1124956T1 (el) Συριγγα
IN2015KN00386A (fr)
UA78360U (en) Use of 1-[n-(isononyl-2-hydroxybenzolmethan)-1-(2-ethylamine)-2-(alkenyl oleinic acid)-4,5-dihydro-1h-imidazolin-dioleate as antioxidant and detergent additive for hydrocarbon adsorbents
IN2013CH05395A (fr)
UA78284U (en) 5,11- dibenzyl -8-thioxo-13-(2-chlorophenyl)-3,5,7,11- tetraazatricyclo[7.3.1.02,7]tridec-2-ene-1,9-dicarbonitrile

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

RT Complete renunciation

Effective date: 20221121